HRAS and skin carcinoma: The HaCa4 cell line is derived from mouse skin carcinomas, carrying the oncogenic H-Ras G12V mutation and treated with 12-O-tetradecanoylphorbol-13-acetate (TPA), representing the two-stage skin carcinogenesis promotion stage [49,51].